Notice of Technical Assistance Webinar and Frequently Asked Questions (FAQs) for NHLBI HeartShare RFA-HL-21-015 "Clinical Centers (U01)" and RFA-HL-21-016 "Data Translation Center (U54)"
Notice Number:
NOT-HL-20-819

Key Dates

Release Date:

October 9, 2020

Related Announcements

RFA-HL-21-015 - HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)

RFA-HL-21-016 - HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The National Heart, Lung, and Blood Institute (NHLBI) issued Funding Opportunity Announcements (FOAs) on September 14, 2020: RFA-HL-21-015 HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed) and RFA-HL-21-016 HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed) .

A pre-submission technical assistance webinar is being offered to inform potential applicants about RFA-HL-21-015 and RFA-HL-21-016. This will include a review of the purpose and objectives of the FOA, application and peer review requirements, and budget considerations.

All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar to maximize the use of time. Questions should be sent by email to [email protected] by Tuesday, October 20, 2020.

Session date and time:

Thursday, October 22, 2020 at 4:00 pm EST

Join Webex Meeting

Event Password: 1234

Call-in Number (US/Canada): 1-650-479-3208

Meeting Number/Access code:126 213 1268

Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e98ecab4b98adaf6e450590e22d22d5e4

Participation in this webinar, although encouraged, is optional and is not required for the submission of applications in response to RFA-HL-21-015 and/or RFA-HL-21-016. The webinar will be recorded. Responses to questions will be posted on a Frequently Asked Questions (FAQs) page on the NHLBI Website soon thereafter; search by the RFA number (RFA-HL-21-015), or use the following links:

https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements/RFA-HL-21-015

https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements/RFA-HL-21-016

Inquiries

Please direct all inquiries to:

Name: Vandana Sachdev, MD
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices